Sei sulla pagina 1di 58

Nutrition in Patients with Cancer and AID

Click to edit Master subtitle style

7/12/12

Cancer

Characteristics of cancer cells

Uncontrolled cellular reproduction

Cells become independent of normal growth signals

Cells contain abnormal nucleus and cytoplasm Mitosis rate generally increases Nucleus of cells may be abnormal shape with clearly abnormal chromosomes
2Slide 2

7/12/12

Cancer, contd

Carcinogenesis

Process resulting in abnormal cell production

Abnormalities in cell replication


Initiation Promotion Progression


3Slide 3

7/12/12

Cancer, contd

7/12/12

4Slide 4

Cancer, contd
Nutrition factors considered important environmental and lifestyle factors in etiology and prevention of cancer

7/12/12

Nutrition and dietary factors may interact within process of carcinogenesis in all three stages: initiation, promotion, and 5Slide 5 progression

National Cancer Institute guidelines

Do not smoke cigarettes or use other tobacco products Do not drink too much alcohol

Eat five or more daily servings of fruits and vegetables 7/12/12

6Slide 6

Cancer, contd

Nutrition and the diagnosis of cancer

Cancer cachexia

Complex syndrome resulting in severe wasting of lean body mass and weight loss
7Slide 7

7/12/12

Cancer, contd

Benefits of nutritional adequacy

Maintenance of nutritional status


Decreases risk of surgical complications Ensures patients able to meet increased energy and protein requirements Helps to repair and rebuild normal tissues affected by antineoplastic therapy Promotes increased tolerance to therapy Assists in promoting enhanced quality of life
8Slide 8

7/12/12

Cancer, contd

Nutritional effects of cancer treatments

Surgery

7/12/12

Depends on type and extent of surgical resection Resections of any portion of gastrointestinal (GI) tract Energy and protein requirements may need to be increased
9Slide 9

Cancer, contd
Chemotherapy

Most protocols include combination of chemotherapy agents Act by:

Inhibiting one or more steps of DNA synthesis in rapidly proliferating cells characteristic of malignant cell Or by enhancing hosts immune system to allow for improved response to therapy 10Slide 10

7/12/12

Cells of bone marrow and

Cancer, contd

Severity and manifestation of side effects determined by:

Chemotherapy agent Dosage Duration of treatment Rates of metabolism Accompanying drugs Individual tolerance

7/12/12

11Slide 11

Cancer, contd
Radiation therapy

Ionizing radiation used to kill cells by altering DNA of malignant cell Interferes with factors controlling replication Used to treat tumors sensitive to radiation exposure or tumors that cannot be surgically resected Some normal cells 12Slide 12

7/12/12

Cancer, contd

Complications may develop during radiation treatment or become chronic and progress even after treatment completed Primary radiation sites resulting in nutrition problems include:

Head and neck Abdomen and pelvis (GI tract) Central nervous system (CNS)

7/12/12

13Slide 13

Cancer, contd
Bone marrow transplantation

Used to treat certain hematologic malignancies (acute and chronic leukemia and some forms of lymphoma) Used as adjunct therapy for solid tumors such as breast cancer Types of transplant include autologous, allogeneic, and syngeneic Ability to maintain adequate oral intake difficult because of nausea, vomiting, and mucositis
14Slide 14

7/12/12

Cancer, contd

Antineoplastic regimens and BMT result in immunosuppression

Places BMT patient at high risk for infections from bacterial and fungal pathogens Pathogens commonly in environment including fresh fruits and vegetables ordinarily not hazard to healthy people

Low-bacterial diet indicated whenever plasma neutrophil count <1000 mm3

7/12/12

15Slide 15

Food safety guidelines for patients with low immune function or are neutropenic

Avoid undercooked meats and eggs Ensure raw fruits and vegetables washed well and/or peeled (including salads and garnishes) Follow appropriate sanitation guidelines for food preparation and storage 16Slide 16

7/12/12

Cancer, contd
Graft versus host disease (GVHD)

Major complication with allogeneic BMT Best described as reverse rejection

Grafted tissue or organ recognizes hosts cells as foreign

May result in multiple organ damage, but skin, GI tract, and liver of particular concern Nutritional management complicated

May require intense therapy for as long as 1 to 2 years posttransplant

7/12/12

17Slide 17

Cancer, contd
Nutrition therapy

Cancer patients at high risk for malnutrition

Recognizing clinical signs and treating symptoms early helps prevent protein-kcal malnutrition

7/12/12

Nutrition essential 18Slide 18 component of total

Cancer, contd

Anorexia caused by cancer or its treatment

Etiology generally multifactorial


Changes in taste and smell Decreased transit time and subsequent early satiety Opportunistic infections Therapy and other medication side effects Pain Emotional and psychologic effects
19Slide 19

7/12/12

Cancer, contd

Treatment options

Essential to promote adequate nutritional intake Many cancer patients feel loss of control after diagnosis

Managing their nutritional intake assists in regaining control

7/12/12

20Slide 20

Cancer, contd

Essential nutrient density of food stressed

Small, frequent meals Use of high-kcal supplements Pleasant eating environment

Medications successfully stimulate appetite

Megestrol (Megace) Dronabinol (Marinol)

7/12/12

21Slide 21

Cancer, contd
Nausea and vomiting

Nausea and vomiting may result from:


Delayed transit time Physiologic symptoms such as hypercalcemia or central nervous system (CNS) involvement Medications Anticipation on part of patient

7/12/12

22Slide 22

Cancer, contd

Treatment options

First line of treatment

Adequate and aggressive antiemetic therapy

Essential to give medication 60 to 90 minutes before meals

If nausea and vomiting prevented, reduced risk of anticipatory nausea and vomiting Cold foods without odor better tolerated Behavioral strategies such as guided imagery and relaxation techniques successful
23Slide 23

7/12/12

Cancer, contd

Taste abnormalities

Taste alteration causes

Changes or destruction of oral mucosa Presence of tumor byproducts systemically Changes in quantity or quality of saliva Inadequate mouth care Drug-related taste changes
24Slide 24

7/12/12

Cancer, contd

Treatment options

Appropriate to avoid foods that taste bad Important to provide alternate food choices to maintain adequate nutrient intake Tart or spicy foods may enhance intake Guidelines for mouth care essential

7/12/12

25Slide 25

Cancer, contd
Expected outcomes for nutrition therapy
1.

Weight and lean body mass maintained within established goal range Hydration adequate as measured by clinical and physical assessment Adequate energy and protein consumption to perform ADL Comprehension by patient of neutropenic precautions Appropriate and safe use of complementary nutrition therapies by patient
26Slide 26

2.

3.

4.

5. 7/12/12

AIDS
Acquired immunodeficiency syndrome (AIDS)

Retrovirus human immunodeficiency virus (HIV) causes acquired immunodeficiency syndrome (AIDS)

Retrovirus injects its ribonucleic acid (RNA) into target cell Then transcribes RNA into deoxyribonucleic (DNA) using reverse transcriptase enzyme
27Slide 27

7/12/12

AIDS, contd

Goal of treatment regimens


Maintain viral load of <50 copies/mL Adherence to these regimens often difficult

Number and complexity of medications taken daily

7/12/12

28Slide 28

AIDS, contd

Drug resistance can develop if adherence not maintained

Other side effects


Nausea Vomiting Diarrhea Other metabolic changes

7/12/12

29Slide 29

AIDS, contd

Malnutrition in HIV/AIDS

Documented in all stages of HIV infection Malnutrition in HIV/AIDS multifactorial Most nutritional problems coincide with:

Incidence of high viral loads Opportunistic infections Development of viral resistance


30Slide 30

7/12/12

AIDS, contd
AIDS-related wasting syndrome

7/12/12

Involuntary weight loss of >10% in 1 month with presence of chronic diarrhea, weakness, or fever for >30 days in absence of concurrent illness or condition

31Slide 31

AIDS, contd
Malnutrition in HIV/AIDS multifactorial

Contributors include:

Altered nutrient intake Weight loss and body composition changes Physical impairment Endocrine disorders Metabolic changes Malabsorption Presence of opportunistic infections Psychosocial issues Economic conditions 32Slide 32

7/12/12

AIDS, contd

Altered nutrient intake

Anorexia frequent symptom may be caused by:


HIV infection Presence of opportunistic infections Fatigue Fever Medication side effects Physical impairment

7/12/12

33Slide 33 Mucositis, esophagitis, pain, nausea, and vomiting

AIDS, contd

Chronic weight loss Acute weight loss


Accompanied by increase in metabolic rate decrease in metabolic rate Reliance on glucose as fuel fat stores for energy Depletion of lean body mass

7/12/12

34Slide 34

AIDS, contd

Medications to treat weight loss


Megestrol acetate (Megace) Dronabinol (Marinol)

Antiemetic Appetite stimulant

Side effects include euphoria, dizziness, and impaired thinking

Oxandrolone (Oxandrine) or oxymetholone and testosterone

7/12/12

Increases lean body mass, mood elevation, and increased libido 35Slide 35

AIDS, contd
Physical impairment

Nausea, vomiting, mouth, and esophageal lesions, and impaired dentition may result from:

Opportunistic infections such as candidiasis and gingivitis Side effects of antiretroviral therapy Prophylactic treatment to prevent opportunistic 36Slide 36 infections

7/12/12

AIDS, contd

Endocrine and metabolic disorders

Hypogonadism identified with HIV/AIDS

Condition associated with fatigue, decreased libido, loss of muscle mass, muscle weakness, impotence, and body hair loss Adrenal insufficiency may contribute to changes in appetite, loss of fuel

7/12/12

37Slide 37

AIDS, contd
Fat redistribution syndrome (lipodystrophy)

Syndrome of body composition changes and metabolic disturbances

Shift in adiposity with increase in abdominal obesity Accompanied by increase in serum triglycerides, cholesterol, glucose, and insulin resistance

Etiology of fat redistribution syndrome associated with protease inhibitors as well as nucleoside analog therapy
38Slide 38

7/12/12

AIDS, contd
Malabsorption

Malabsorption result of:


Opportunistic infections that damage GI tract Effects of malnutrition on villus height and enterocyte function Disease itself

Treatment of malabsorption

Treating underlying cause crucial in reversing malnutrition caused by malabsorption


39Slide 39

7/12/12

AIDS, contd

To assist control of malabsorptive symptoms and diarrhea:

Restriction of fat and lactose common Lactose-free supplements and supplements containing medium-chain triglycerides frequently prescribed Probiotics and prebiotics, glutamine and arginine in enteral products or given separately as supplement

Ensure adequate caloric and protein intake as fat and lactose restricted Prevent dehydration

Fluid losses may be high from diarrhea Supplementation with vitamins and minerals priority 40Slide 40

7/12/12

AIDS, contd

Cycle of malnutrition and wasting

Complex causes

Interventions must be integrated early Conducting nutrition assessment and providing counseling result weight maintenance or gain

7/12/12

41Slide 41

AIDS, contd

Nutrition assessment in cancer and HIV/AIDS

Initial step evaluate anthropometric data

Body weight compared with the clients usual body weight

Unexplained weight loss concern

Weight loss >10% in 6 months places client at risk BMI <18 associated with malnutrition 42 42Slide

Body mass index (BMI) identifies nutrition risk

7/12/12

AIDS, contd

Loss of lean body mass characteristic of malnutrition of AIDS

Weight may initially be stable Bioelectrical impedance (BIA) evaluates changes Calculation of upper arm muscle area can provide baseline measurement for monitoring over time

7/12/12

43Slide 43

AIDS, contd

Biochemical indices

Monitoring disease progression (CD4 or viral load) Acute phase proteins measuring inflammatory processes (C-reactive protein) Overall visceral protein stores (serum albumin and prealbumin) Other measures such as transferrin not applicable (possible bone marrow suppression present)
44Slide 44

7/12/12

AIDS, contd

Dietary assessment

Dietary evaluation by:

24-hour recall Food frequency Food diary

7/12/12

45Slide 45

AIDS, contd

Careful attention

Gastrointestinal function Presence of steatorrhea and diarrhea Other physical symptoms that might interfere with adequate oral intake

7/12/12

46Slide 46

AIDS, contd

Nutrition therapy

Overall goals of nutrition management


Preserve lean body mass and gut function Prevent development of malnutrition Minimize symptoms of malabsorption Provide adequate levels of all nutrients to maintain daily physical and mental functioning Prevent nutrition-related immunosuppression Improve quality of life
47Slide 47

7/12/12

AIDS, contd

Objectives of nutrition care


Realistic and individualized objectives Interventions designed based on:

Nutritional assessment Current medical treatment for client

7/12/12

48Slide 48

AIDS, contd

To determine energy and protein requirements

Harris-Benedict equation to determine resting energy expenditure (REE)

1.3 to 1.5 REE should meet most clients energy requirements for maintenance and weight gain MifflinSt. Jeor equation may better predict energy requirements for hospitalized patient

7/12/12

49Slide 49

AIDS, contd
MifflinSt. Jeor Equation
Females: 10 W + 6.25 H 5 A 161 Males: 10 W + 6.25 H 5 A + 5

W = Weight (in kg) H = Height (in cm) A = Age (in years)

7/12/12

50Slide 50

AIDS, contd

Protein requirements

1 to 1.5 g protein/kg of actual body weight based on patients current nutritional status

Vitamin and mineral status needs to be monitored closely because deficiencies may evolve

Suppressed oral intake Increased requirements for certain micronutrients

General multivitamin supplement meeting 100% of the Recommended Dietary Allowance (RDA) for vitamins and minerals routinely recommended In individual situations, other supplements may be warranted 51Slide 51

7/12/12

AIDS, contd

Antiretroviral therapy

Antiretroviral therapy requires specific nutrition recommendations

Many antiretroviral medications result in symptoms such as nausea, vomiting, diarrhea, or anorexia that might impair oral intake Number of pills taken can overwhelm patient Ingestion of food along with certain medications may affect absorption of that drug or vice versa

7/12/12

52Slide 52

AIDS, contd

Specific nutrition recommendations include:

Efavirenz (Sustiva)

Avoid taking with high-fat meals Moderate-fat meals increase availability of capsules Take with food

Lopinavir (Kaletra) + ritonavir (Norvir)

7/12/12

53Slide 53

AIDS, contd

Saquinavir (Invirase)

Take within 2 hours of meal of high-fat foods or large snack containing carbohydrate, protein, or fat Taking with food may decrease abdominal cramping and diarrhea common when this drug initially prescribed Symptoms usually disappear within 8 weeks

Ritonavir (Norvir)

7/12/12

54Slide 54

AIDS, contd

Indinavir (Crixivan)

Taken on empty stomach Meal can be eaten 1 hour after drug or 2 hours before drug For some, may be necessary to eat small snack with drug, but fat should be avoided

7/12/12

55Slide 55

AIDS, contd

Prevention of foodborne illness

Crucial component of nutrition therapy and education for HIV/AIDS

As CD4 counts fall, higher risk for infections from foods

Nutrition education focus on safe methods for food purchasing, preparation, and storage

7/12/12

56Slide 56

AIDS, contd

Low microbial diet prescribed with recommendations to avoid:


Undercooked meats and eggs Raw vegetables Fruits

7/12/12

57Slide 57

AIDS, contd

Physical activity

Regular aerobic exercise and resistance training assist with:


Lipid abnormalities Fat redistribution syndrome Other body composition changes

Recommendations individualized and initiated slowly after physicians approval


58Slide 58

7/12/12

Potrebbero piacerti anche